The vaccine is surface glycoproteins (hemagglutinin and neuraminidase) isolated from purified virions of influenza virus type A and B obtained from the virus-containing allantoic fluid of chicken embryos of clinically healthy chickens and diluted in phosphate buffered saline in combination with azoximer bromide (Polyoxidonium). The product does not contain a preservative or contains the preservative thiomersal (merthiolate).

The vaccine is surface glycoproteins (hemagglutinin and neuraminidase) isolated from purified virions of influenza virus types A and B obtained from the virus-containing allantoic fluid from chick embryos of clinically healthy chickens and diluted in phosphate-buffered saline in combination with adjuvant SOVIDON TM. The drug is available with the preservative thiomersal (merthiolate) or without a preservative. <br>
The antigenic structure of the strains is varied each year according to guidelines of the WHO and the Commission on Influenza Vaccines and diagnostic strains of the Russian Ministry of Health.

The live tissue culture measles vaccine, lyophilisate for the solution for subcutaneous injection, is prepared by cultivation of the vaccine strain of Leningrad-16 (L-16) measles virus on the primary culture of quail embryo cells.

Administration of the preparation in accordance with the approved schedule leads to the development of specific immunity to pertussis, diphtheria and tetanus.

The tissue culture mumps-measles vaccine, lyophilisate for the solution for subcutaneous injection, is a lyophilized mixture of liquid semi-products of measles and mumps vaccines prepared by culturing attenuated strains of the measles virus L-16 and the mumps virus L-3 on a primary culture of quail embryo cells.

The vaccine EnceVir®Neo for children is a special sterile purified concentrated suspense of a tick-borne formalin-inactivated virus (strain 205) obtained by reproduction on the weighted on the culture of chick embryo cells adsorbed on aluminum hydroxide.